Transpapillary vs. intraductal fully covered selfexpanding metal stent placement for malignant and benign biliary disease: does it make a difference?

Brijbassie, Alan

doi:10.7178/jig.192

Cited by 1 publication

(13 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our systematic search identified 13 eligible publications out of 3912 records. Thirteen articles were eligible [3,8,12,[22][23][24][25][26][27][28][29][30][31] for qualitative synthesis, and twelve were included in the quantitative synthesis [3,8,12,[22][23][24][25][26][27][28][29]31]. The reasons for excluding specific publications on the full-text level are presented in Supplementary Table S1.…”

Section: Systematic Search and Selectionmentioning

confidence: 99%

“…Three prospective [8,12,28] and ten retrospective studies [3,[22][23][24][25][26][27][29][30][31] were identified during the literature search. Only two studies were RCTs [12,28].…”

Section: Description Of the Selected Studiesmentioning

confidence: 99%

“…The eligible articles were published between 1992 and 2019, mainly in Asia [3,8,[24][25][26][27][28]30]. Two studies were published in North America [22,23] and one in Europe [12]. Two of the studies were multicentric [23,28], while the others were single-center studies [3,8,12,22,[24][25][26][27]30], or data were not available regarding this information [29,31].…”

Section: Description Of the Selected Studiesmentioning

confidence: 99%

“…Two studies were published in North America [22,23] and one in Europe [12]. Two of the studies were multicentric [23,28], while the others were single-center studies [3,8,12,22,[24][25][26][27]30], or data were not available regarding this information [29,31]. In 12 publications, only malignant etiologies were analyzed [3,8,12,[23][24][25][26][27][28][29][30][31] and in one study, both benign and malignant etiologies of biliary obstruction were analyzed [22].…”

Section: Description Of the Selected Studiesmentioning

confidence: 99%

“…Stent patency time was analyzed in 11 studies involving 875 patients [3,8,12,[22][23][24][25][26][27][28]31]. Stent patency time was significantly longer in the SPS group (WMD = 50.23 days, 95% CI: 8.56; 91.89; p = 0.018; heterogeneity: I 2 = 77%, p < 0.001) (Figure 2).…”

Section: Stent Patencymentioning

confidence: 99%

See 4 more Smart Citations

Suprapapillary Biliary Stents Have Longer Patency Times than Transpapillary Stents—A Systematic Review and Meta-Analysis

Kovács

Pécsi

Sipos

et al. 2023

JCM

View full text Add to dashboard Cite

Background and study aims: Endoscopic biliary stent placement is a minimally invasive intervention for patients with biliary strictures. Stent patency and function time are crucial factors. Suprapapillary versus transpapillary stent positioning may contribute to stent function time, so a meta-analysis was performed in this comparison. Methods: A comprehensive literature search was conducted in the CENTRAL, Embase, and MEDLINE databases to find data on suprapapillary stent placement compared to the transpapillary method via endoscopic retrograde cholangiopancreatography in cases of biliary stenosis of any etiology and any stent type until December 2020. We carried out a meta-analysis focusing on the following outcomes: stent patency, stent migration, rate of cholangitis and pancreatitis, and other reported complications. Results: Three prospective and ten retrospective studies involving 1028 patients were included. Suprapapillary stent placement appeared to be superior to transpapillary stent positioning in patency (weighted mean difference = 50.23 days, 95% CI: 8.56, 91.98; p = 0.0.018). In a subgroup analysis of malignant indications, suprapapillary positioning showed a lower rate of cholangitis (OR: 0.34, 95% CI: 0.13, 0.93; p = 0.036). Another subgroup analysis investigating metal stents in a suprapapillary position resulted in a lower rate of pancreatitis (OR: 0.16, 95% CI: 0.03, 0.95; p = 0.043) compared to transpapillary stent placement. There was no difference in stent migration rates between the two groups (OR: 0.67, 95% CI: 0.17, 2.72; p = 0.577). Conclusions: Based on our results, suprapapillary biliary stenting has longer stent patency. Moreover, the stent migration rate did not differ between the suprapapillary and transpapillary groups.

show abstract

Section: Systematic Search and Selectionmentioning

confidence: 99%

“…Three prospective [8,12,28] and ten retrospective studies [3,[22][23][24][25][26][27][29][30][31] were identified during the literature search. Only two studies were RCTs [12,28].…”

Section: Description Of the Selected Studiesmentioning

confidence: 99%